The BioE3 Policy represents not only a policy shift but also a national commitment to drive bio-innovation through structured ...

Clinical Trials in India have gained global attention for their rapid growth, world-class infrastructure, and access to a diverse patient population. With increasing support from regulatory bodies and ...

Discover India's leading AI development companies for 2025! This curated list highlights the top 10 providers offering ...

The BioScience Alliance in Westlake Village, Ventura County’s 2nd District, the Economic Development Collaborative and India’s Atal Incubation Centre have entered into an agreement aimed at ...

Alvotech faces challenges with potential tariffs and profitability, despite strong revenue growth and a robust pipeline. See ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

Preetika Rana is an award-winning reporter for The Wall Street Journal in San Francisco with experience reporting from six ...

In this interview with Sakshi Batra of Business Today, Peter Bains, Managing Director and CEO of Syngene International, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

greater control over the biotech company’s operations. Pete Salzmann, Immunovant’s current CEO and board member, is retiring. He will be replaced by Eric Venker, Roivant’s current president ...